193 related articles for article (PubMed ID: 20422403)
1. The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on behavioural responses to nicotine.
Tronci V; Vronskaya S; Montgomery N; Mura D; Balfour DJ
Psychopharmacology (Berl); 2010 Jul; 211(1):33-42. PubMed ID: 20422403
[TBL] [Abstract][Full Text] [Related]
2. Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) microinfusions into the nucleus accumbens shell or ventral tegmental area attenuate the reinforcing effects of nicotine in rats.
D'Souza MS; Markou A
Neuropharmacology; 2011 Dec; 61(8):1399-405. PubMed ID: 21896278
[TBL] [Abstract][Full Text] [Related]
3. Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats.
Bespalov AY; Dravolina OA; Sukhanov I; Zakharova E; Blokhina E; Zvartau E; Danysz W; van Heeke G; Markou A
Neuropharmacology; 2005; 49 Suppl 1():167-78. PubMed ID: 16023685
[TBL] [Abstract][Full Text] [Related]
4. The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice.
Paterson NE; Semenova S; Gasparini F; Markou A
Psychopharmacology (Berl); 2003 May; 167(3):257-64. PubMed ID: 12682710
[TBL] [Abstract][Full Text] [Related]
5. Metabotropic glutamate 5 receptor (mGluR5) antagonists decrease nicotine seeking, but do not affect the reinforcement enhancing effects of nicotine.
Palmatier MI; Liu X; Donny EC; Caggiula AR; Sved AF
Neuropsychopharmacology; 2008 Aug; 33(9):2139-47. PubMed ID: 18046312
[TBL] [Abstract][Full Text] [Related]
6. The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on the stimulation of dopamine release evoked by nicotine in the rat brain.
Tronci V; Balfour DJ
Behav Brain Res; 2011 Jun; 219(2):354-7. PubMed ID: 21216262
[TBL] [Abstract][Full Text] [Related]
7. Metabotropic glutamate receptor 5 activity in the nucleus accumbens is required for the maintenance of ethanol self-administration in a rat genetic model of high alcohol intake.
Besheer J; Grondin JJ; Cannady R; Sharko AC; Faccidomo S; Hodge CW
Biol Psychiatry; 2010 May; 67(9):812-22. PubMed ID: 19897175
[TBL] [Abstract][Full Text] [Related]
8. Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking.
Tessari M; Pilla M; Andreoli M; Hutcheson DM; Heidbreder CA
Eur J Pharmacol; 2004 Sep; 499(1-2):121-33. PubMed ID: 15363959
[TBL] [Abstract][Full Text] [Related]
9. Operant responding for conditioned and unconditioned reinforcers in rats is differentially enhanced by the primary reinforcing and reinforcement-enhancing effects of nicotine.
Chaudhri N; Caggiula AR; Donny EC; Booth S; Gharib M; Craven L; Palmatier MI; Liu X; Sved AF
Psychopharmacology (Berl); 2006 Nov; 189(1):27-36. PubMed ID: 17019569
[TBL] [Abstract][Full Text] [Related]
10. Nicotine and cocaine self-administration using a multiple schedule of intravenous drug and sucrose reinforcement in rats.
Stairs DJ; Neugebauer NM; Bardo MT
Behav Pharmacol; 2010 May; 21(3):182-93. PubMed ID: 20440201
[TBL] [Abstract][Full Text] [Related]
11. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
Liechti ME; Markou A
Eur J Pharmacol; 2007 Jan; 554(2-3):164-74. PubMed ID: 17113075
[TBL] [Abstract][Full Text] [Related]
12. The effects of response operandum and prior food training on intravenous nicotine self-administration in rats.
Clemens KJ; Caillé S; Cador M
Psychopharmacology (Berl); 2010 Jul; 211(1):43-54. PubMed ID: 20437028
[TBL] [Abstract][Full Text] [Related]
13. The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats.
Schroeder JP; Overstreet DH; Hodge CW
Psychopharmacology (Berl); 2005 Apr; 179(1):262-70. PubMed ID: 15717208
[TBL] [Abstract][Full Text] [Related]
14. The mGlu5 receptor antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) supports intravenous self-administration and induces conditioned place preference in the rat.
van der Kam EL; De Vry J; Tzschentke TM
Eur J Pharmacol; 2009 Apr; 607(1-3):114-20. PubMed ID: 19326478
[TBL] [Abstract][Full Text] [Related]
15. Effects of MPEP on locomotion, sensitization and conditioned reward induced by cocaine or morphine.
Herzig V; Schmidt WJ
Neuropharmacology; 2004 Dec; 47(7):973-84. PubMed ID: 15555632
[TBL] [Abstract][Full Text] [Related]
16. A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats.
Keck TM; Zou MF; Bi GH; Zhang HY; Wang XF; Yang HJ; Srivastava R; Gardner EL; Xi ZX; Newman AH
Addict Biol; 2014 Mar; 19(2):195-209. PubMed ID: 24001208
[TBL] [Abstract][Full Text] [Related]
17. Nicotine-induced conditioned place preference in rats: sex differences and the role of mGluR5 receptors.
Yararbas G; Keser A; Kanit L; Pogun S
Neuropharmacology; 2010 Feb; 58(2):374-82. PubMed ID: 19833142
[TBL] [Abstract][Full Text] [Related]
18. mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties.
Swedberg MD; Ellgren M; Raboisson P
J Pharmacol Exp Ther; 2014 Apr; 349(1):155-64. PubMed ID: 24472725
[TBL] [Abstract][Full Text] [Related]
19. Role of gamma-aminobutyric acid (GABA) and metabotropic glutamate receptors in nicotine reinforcement: potential pharmacotherapies for smoking cessation.
Markou A; Paterson NE; Semenova S
Ann N Y Acad Sci; 2004 Oct; 1025():491-503. PubMed ID: 15542754
[TBL] [Abstract][Full Text] [Related]
20. Effects of the selective dopamine D3 receptor antagonist SB-277011A on the reinforcing effects of nicotine as measured by a progressive-ratio schedule in rats.
Ross JT; Corrigall WA; Heidbreder CA; LeSage MG
Eur J Pharmacol; 2007 Mar; 559(2-3):173-9. PubMed ID: 17303116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
